Our Pricing

Mounjaro Monthly Cost UK - Safe with Methotrexate

Published on: June 03, 2026

Understanding Mounjaro monthly cost UK safe with methotrexate is essential for patients managing both weight loss and autoimmune conditions. At Cured Pharmacy, Mounjaro (tirzepatide) starts from £124.99 per month, and our UK prescribers routinely assess patients taking methotrexate to ensure safe, effective treatment. This guide explains the safety profile, drug interactions, and transparent pricing you need to make an informed decision.

Is Mounjaro Safe to Take with Methotrexate?

Mounjaro (tirzepatide) does not have any known direct pharmacokinetic interactions with methotrexate. Methotrexate is primarily eliminated renally and through hepatic metabolism, whilst tirzepatide is metabolised via proteolytic cleavage and does not rely on cytochrome P450 enzymes [1]. This distinct metabolic pathway means the two medications can typically be prescribed together under appropriate clinical supervision.

However, patients on methotrexate often have underlying conditions such as rheumatoid arthritis, psoriasis, or inflammatory bowel disease that require individualised assessment. Your UK prescriber will review your complete medication history, liver function, renal status, and disease stability before approving Mounjaro [2]. Both medications can cause gastrointestinal side effects, so monitoring is essential to distinguish between expected tirzepatide effects (nausea, reduced appetite) and potential methotrexate-related complications.

At Cured Pharmacy, our clinical team assesses every patient individually. If you're on methotrexate, your online consultation will include specific questions about your dosing schedule, blood monitoring results, and any existing side effects to ensure Mounjaro is appropriate for your circumstances.

Mounjaro Monthly Cost UK: Transparent Pricing Breakdown

Mounjaro pricing in the UK varies by dose strength, with monthly costs reflecting your prescribed maintenance level. At Cured Pharmacy, Mounjaro starts from £124.99 per month with transparent upfront pricing before you complete your consultation. Unlike some providers, we display exact costs so you can budget confidently without hidden fees or subscription traps.

Your starting dose will typically be 2.5 mg once weekly for the first four weeks (one pen supplies one month), escalating to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or the maximum 15 mg dose depending on your response and tolerability [3]. Most patients reach their maintenance dose within 16-20 weeks. Our UK prescribers determine your appropriate dose based on weight loss progress, side effect profile, and clinical goals during follow-up assessments.

Cured Pharmacy guarantees the lowest prices in the UK for genuine, MHRA-licensed Mounjaro. Every prescription includes free clinical consultation, discreet packaging, and delivery direct to your door. There are no membership fees, and you only pay for the medication you need each month.

What's Included in Your Monthly Cost

Your Mounjaro monthly cost at Cured Pharmacy covers the KwikPen injector pre-filled with four weekly doses, free online consultation with a UK prescriber, prescription review and approval, discreet home delivery, and ongoing clinical support. Follow-up consultations for dose adjustments are provided at no additional charge, ensuring continuity of care throughout your weight loss journey.

How Mounjaro Works: Dual GIP/GLP-1 Mechanism

Mounjaro contains tirzepatide, the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed for weight management in the UK [1]. This dual mechanism activates two complementary pathways that regulate appetite, slow gastric emptying, and improve insulin sensitivity more effectively than single-pathway treatments.

In the landmark SURMOUNT-1 trial, patients taking the 15 mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks, significantly outperforming placebo and historical comparisons with semaglutide-based therapies [3]. The dual agonist approach appears to produce greater satiety and metabolic benefits, though individual results vary based on adherence, lifestyle factors, and baseline characteristics.

For patients on methotrexate managing conditions like rheumatoid arthritis or psoriasis, achieving and maintaining a healthy weight can reduce inflammatory burden, improve joint mobility, and enhance overall disease control [4]. Mounjaro's once-weekly injection schedule also offers convenience for patients already managing complex medication regimens.

Expected Timeline and Results

Most patients begin noticing appetite suppression within the first week of Mounjaro treatment, with measurable weight loss typically evident by week four. Optimal results occur during the maintenance phase (months 4-12), when you've reached your target dose and established sustainable eating patterns. Clinical trials showed continued weight loss through 72 weeks, with many patients maintaining reductions beyond that timeframe when treatment continued [3].

Managing Side Effects: Mounjaro and Methotrexate Considerations

The most common Mounjaro side effects include nausea (affecting up to 30% of patients), diarrhoea, reduced appetite, vomiting, and constipation, particularly during dose escalation [3]. These gastrointestinal effects are usually mild to moderate and diminish as your body adjusts. For patients on methotrexate, distinguishing between tirzepatide-related nausea and methotrexate-associated symptoms is important for appropriate management.

Methotrexate itself commonly causes nausea, fatigue, and gastrointestinal upset, especially in the 24-48 hours following your weekly dose. If you're starting Mounjaro whilst on established methotrexate therapy, consider timing your tirzepatide injection on a different day of the week to help identify which medication might be contributing to any side effects. Your UK prescriber can provide specific guidance based on your methotrexate dosing schedule.

Both medications require monitoring, though for different reasons. Methotrexate necessitates regular blood tests to assess liver function, renal function, and blood counts. Mounjaro doesn't typically require routine blood monitoring unless you have diabetes or other comorbidities, but your prescriber may recommend periodic checks to assess metabolic parameters and ensure treatment safety [2].

When to Contact Your Prescriber

Seek immediate medical advice if you experience severe abdominal pain, persistent vomiting preventing fluid intake, signs of pancreatitis, visual changes, or symptoms of thyroid nodules (neck lump, difficulty swallowing, persistent hoarseness). For patients on methotrexate, also report any new mouth ulcers, unusual bruising, severe fatigue, or signs of infection, as these may indicate methotrexate toxicity requiring urgent assessment [4].

Alternative Weight Loss Treatments at Cured Pharmacy

Whilst Mounjaro offers the highest average weight loss in clinical trials, other licensed treatments may be more suitable depending on your medical history, budget, and treatment goals. Cured Pharmacy offers a comprehensive range of MHRA-approved weight loss medications, all requiring clinical assessment by our UK prescribers.

Wegovy (semaglutide) is a once-weekly GLP-1 receptor agonist that demonstrated average weight loss of 14.9% over 68 weeks in the STEP-1 trial [5]. It works through a single pathway compared to Mounjaro's dual mechanism but remains highly effective and may be preferred for patients with specific contraindications or cost considerations. Saxenda (liraglutide) offers a daily injection option for patients who prefer more frequent, lower-dose administration.

For patients seeking non-injectable options, Orlistat and its branded versions (Xenical, Alli, Orlos) work by blocking fat absorption in the digestive system. These medications suit patients who prefer oral treatment or have contraindications to GLP-1 therapies. Your UK prescriber will discuss all suitable options during your consultation, considering your methotrexate therapy and overall health profile.

Starting Mounjaro with Cured Pharmacy: What to Expect

Beginning your Mounjaro treatment at Cured Pharmacy is straightforward and designed for patients managing complex medication regimens. Start by completing our free online consultation, which takes under three minutes and includes specific questions about your current medications, including methotrexate dose, frequency, and monitoring schedule. Be prepared to provide information about your prescribing specialist, recent blood test results, and any side effects you experience.

Our UK-registered prescribers review every consultation individually, typically within 24 hours. For patients on methotrexate, we may request additional information about your underlying condition, disease stability, and recent liver function tests to ensure safe prescribing. Once approved, your Mounjaro prescription is dispensed from our GPhC-registered pharmacy and delivered discreetly to your home, usually within 1-3 working days.

Your first Mounjaro pen will be the 2.5 mg starter dose, containing four weekly injections. We provide comprehensive injection technique guidance, storage instructions, and advice on managing potential side effects. Follow-up consultations for dose escalation are included at no extra cost, allowing your prescriber to adjust your treatment based on your progress and tolerability. Throughout your treatment, our clinical team remains available for questions about Mounjaro and its compatibility with your methotrexate therapy.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. Retrieved from https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency [accessed 13 August 2026]
3. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of tirzepatide on glycemic control and body weight in participants with type 2 diabetes mellitus and obesity: SURPASS-4 extension study. Diabetes, Obesity and Metabolism, 25(4), 1156–1165. https://doi.org/10.1111/dom.14967 [accessed 13 August 2026]
4. Versini, M., Jeandel, P. Y., Rosenthal, E., & Shoenfeld, Y. (2014). Obesity in autoimmune diseases: Not a passive bystander. Autoimmunity Reviews, 13(9), 981–1000. https://doi.org/10.1016/j.autrev.2014.07.001 [accessed 13 August 2026]
5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication, particularly if you are taking methotrexate or other immunosuppressive therapies. Individual results may vary.